Novel Testing Strategies for Endocrine Disruptors in the Context of Developmental Neurotoxicity; ENDPOINTS
Funder: European CommissionDuration: January 2019 - January 2024
People
Name | Telephone | Office | ||
---|---|---|---|---|
Mr Martin Scholze Research Fellow (Principal investigator)
E: martin.scholze@brunel.ac.uk
|
martin.scholze@brunel.ac.uk | Heinz Wolff 001 |
Outputs
Keßel, HE., Masjosthusmann, S., Bartmann1, K., Blum, J., Dönmez, A., Förster, N., et al. (2023) 'The impact of biostatistics on hazard characterization using in vitro developmental neurotoxicity assays'. ALTEX : Alternatives to Animal Experimentation, 40 (4). pp. 619 - 634. ISSN: 0946-7785 Open Access Link
Blum, J., Masjosthusmann, S., Bartmann, K., Bendt, F., Dolde, X., Dönmez, A., et al. (2022) 'Establishment of a human cell-based in vitro battery to assess developmental neurotoxicity hazard of chemicals'. Chemosphere, 311 (Pt 2). pp. 1 - 158. ISSN: 0045-6535 Open Access Link
Lupu, D., Andersson, P., Bornehag, C-G., Demeneix, B., Fritsche, E., Gennings, C., et al. (2020) 'The endpoints project: Novel testing strategies for endocrine disruptors linked to developmental neurotoxicity'. International Journal of Molecular Sciences, 21 (11). pp. 1 - 16. ISSN: 1661-6596 Open Access Link